SCHEMBL4248716

SCHEMBL4248716

CCCCCCCCOC(O)C(C)O

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 1/20 0.47
HTT P42858 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
THRB P10828 1/20 0.45
MAPT P10636 1/20 0.45
USP2 O75604 1/20 0.44
SPHK1 Q9NYA1 1/20 0.43
LMNA P02545 2/20 0.40
ALDH1A1 P00352 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TSHR P16473 1/20 0.40
LPAR1 Q92633 3/20 0.40
LPAR3 Q9UBY5 3/20 0.40
LPAR2 Q9HBW0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16004875 1.00 DNM1 (0.47) DNM1HTTMEN1KMT2ATHRB
SCHEMBL10441897 1.00 DNM1 (0.47) DNM1HTTMEN1KMT2ATHRB
SCHEMBL4244283 1.00 DNM1 (0.47) DNM1HTTMEN1KMT2ATHRB
SCHEMBL31253233 1.00 DNM1 (0.47) DNM1HTTMEN1KMT2ATHRB
SCHEMBL409835 1.00 DNM1 (0.47) DNM1HTTMEN1KMT2ATHRB
SCHEMBL4244542 1.00 DNM1 (0.47) DNM1HTTMEN1KMT2ATHRB
SCHEMBL10441645 1.00 DNM1 (0.47) DNM1HTTMEN1KMT2ATHRB
SCHEMBL10379772 0.98 DNM1 (0.43) DNM1HTTMEN1KMT2ATHRB
SCHEMBL1835984 0.91 TSHR (0.42) DNM1HTTMEN1KMT2ATHRB
SCHEMBL5415141 0.89 ALDH1A1 (0.54) ALDH1A1LPAR1LPAR3LPAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260041095-A1 A PRESERVATION METHOD ANALYTICON DISCOVERY ZWEIGNIEDERLASSUNG DER BRAIN BIOTECH AG (DE) 2026-02-12 US claimed
US-20260034044-A1 A PRESERVATIVE COMPOSITION ANALYTICON DISCOVERY ZWEIGNIEDERLASSUNG DER BRAIN BIOTECH AG (DE) 2026-02-05 US claimed
EP-4565196-A1 A PRESERVATIVE COMPOSITION AnalytiCon Discovery - Zweigniederlassung der BRAIN Biotech AG (DE) 2025-06-11 EP claimed
EP-4565065-A1 A PRESERVATION METHOD AnalytiCon Discovery - Zweigniederlassung der BRAIN Biotech AG (DE) 2025-06-11 EP claimed
EP-4565197-A1 A PRESERVATIVE COMPOSITION AnalytiCon Discovery - Zweigniederlassung der BRAIN Biotech AG (DE) 2025-06-11 EP claimed
EP-4450128-A2 ANTIMICROBIAL COMPOSITIONS Symrise AG (DE) 2024-10-23 EP claimed
CN-112996489-B Sol-gel composition 株式会社爱茉莉太平洋 2024-08-02 CN claimed
EP-4376798-A1 PRESERVATIVES FOR COSMETIC AND PHARMACEUTICAL COMPOSITIONS Sachem, Inc. (US) 2024-06-05 EP claimed
US-11998633-B2 Topical sol-gel composition for the treatment of dermatitis AMOREPACIFIC CORPORATION (KR) 2024-06-04 US claimed
US-20240058243-A1 A METHOD FOR FIGHTING MICROORGANISMS USING MENTHOL DERIVATIVES SYMRISE AG (DE) 2024-02-22 US claimed
CN-110693754-A Antibacterial and anti-inflammatory pyridone composition and cosmetic containing same 烟台东方化学有限公司 2020-01-17 CN claimed
CN-110664633-A Anticorrosion synergistic composition and application thereof 烟台东方化学有限公司 2020-01-10 CN claimed
CN-110664658-A Whitening antibacterial composition and cosmetic containing same 菏泽新东方日化科技有限公司 2020-01-10 CN claimed
US-20190282478-A1 ANTIMICROBIAL COMPOSITIONS SYMRISE AG (DE) 2019-09-19 US claimed
EP-3525587-A1 ANTIMICROBIAL COMPOSITIONS Symrise AG (DE) 2019-08-21 EP claimed
EP-2774481-B1 Antimicrobial compositions SYMRISE AG (DE) 2018-06-13 EP claimed
WO-2018068825-A1 ANTIMICROBIAL COMPOSITIONS SYMRISE AG (DE) 2018-04-19 WO claimed
US-20160015031-A1 Antimicrobial Compositions SYMRISE AG (DE) 2016-01-21 US claimed
WO-2014135650-A1 ANTIMICROBIAL COMPOSITIONS SYMRISE AG (DE) 2014-09-12 WO claimed
EP-2774481-A1 Antimicrobial compositions Symrise AG (DE) 2014-09-10 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260041095-A1 A PRESERVATION METHOD LSS, ASAH2, CUTA DNM1 3155/4885HTT 4640/4885MEN1 1759/4885
US-20190282478-A1 ANTIMICROBIAL COMPOSITIONS MPO, NHERF1, NOX1 DNM1 220/4885HTT 1920/4885MEN1 967/4885
US-20240058243-A1 A METHOD FOR FIGHTING MICROORGANISMS USING MENTHOL DERIVATIVES MGLL, GCDH, GK DNM1 1242/4885HTT 4139/4885MEN1 777/4885
US-20260034044-A1 A PRESERVATIVE COMPOSITION ERG28, FOXO3, DEGS1 DNM1 2278/4885HTT 3984/4885MEN1 1446/4885
US-20160015031-A1 Antimicrobial Compositions CUTA, ARG1, POLR1C DNM1 1265/4885HTT 1793/4885MEN1 882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.